Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

DOT Laser Offers Low Incidence of Adverse Effects

J Drugs Dermatol; 2018 Nov; Sarnoff, Gotkin, et al

Microablative fractional resurfacing with the dermal optical thermolysis (DOT) laser enables treatment of a diversity of skin conditions with short post-procedure recovery time and an extremely low incidence of adverse side effects. This according to a recent study that aimed to evaluate the incidence of adverse effects following laser skin resurfacing with the microablative carbon dioxide (CO2) laser system. Researchers conducted a retrospective chart review and data was collected for DOT laser procedures performed at 3 clinical centers from 2008-2014. They found:

  • Of the 1,081 DOT laser procedures, there were 13 complications (1.3% of all cases), which included 11 cases of prolonged erythema and 2 cases of post-inflammatory hyperpigmentation.
  • There were no cases of scarring.
Citation:

Sarnoff D, Gotkin RH, Doerfler LB, Gustafson CJ, Hanke CW. The safety of laser skin resurfacing with the microablative carbon dioxide laser and review of the literature. J Drugs Dermatol. 2018;17(11):1157.